1. Risk of Major Malformations Following First-Trimester Exposure to Olanzapine: Preliminary Data From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Issue 2 (March 2023) Authors: Viguera, Adele C.; Freeman, Marlene P.; Kobylski, Lauren A.; Rossa, Ella T.; Gaccione, Peter; Chitayat, David; Hernández-Díaz, Sonia; Cohen, Lee S. Journal: Journal of clinical psychopharmacology Issue: Volume 43:Issue 2(2023) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Risk of major malformations in infants after first‐trimester exposure to benzodiazepines: Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. Issue 12 (31st July 2022) Authors: Szpunar, Mercedes J.; Freeman, Marlene P.; Kobylski, Lauren A.; Caplin, Phoebe S.; Gaccione, Peter; Viguera, Adele C.; Chitayat, David; Hernández‐Díaz, Sonia; Cohen, Lee S. Journal: Depression and anxiety Issue: Volume 39:Issue 12(2022) Page Start: 751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗